Lumbar degenerative disease treated by percutaneous endoscopic transforaminal lumbar interbody fusion or minimally invasive surgery-transforaminal lumbar interbody fusion: a case-matched comparative study

Abstract Purpose This study aimed to evaluate the clinical efficacy and imaging results of percutaneous endoscopic transforaminal lumbar interbody fusion (PETLIF) through comparing it with minimally invasive surgery-transforaminal lumbar interbody fusion (MISTLIF). Materials and methods We performed...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: You-Di Xue, Wen-Bo Diao, Chao Ma, Jie Li
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/d0a846fb03334701a23323bcb96faaef
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d0a846fb03334701a23323bcb96faaef
record_format dspace
spelling oai:doaj.org-article:d0a846fb03334701a23323bcb96faaef2021-11-28T12:27:03ZLumbar degenerative disease treated by percutaneous endoscopic transforaminal lumbar interbody fusion or minimally invasive surgery-transforaminal lumbar interbody fusion: a case-matched comparative study10.1186/s13018-021-02841-41749-799Xhttps://doaj.org/article/d0a846fb03334701a23323bcb96faaef2021-11-01T00:00:00Zhttps://doi.org/10.1186/s13018-021-02841-4https://doaj.org/toc/1749-799XAbstract Purpose This study aimed to evaluate the clinical efficacy and imaging results of percutaneous endoscopic transforaminal lumbar interbody fusion (PETLIF) through comparing it with minimally invasive surgery-transforaminal lumbar interbody fusion (MISTLIF). Materials and methods We performed a retrospective analysis on patients with lumbar degenerative disease treated by PETLIF or MISTLIF from September 2017 to January 2019, and the patients were divided into two groups: the PETLIF group and the MISTLIF group. The clinical and imaging parameters of the two groups were evaluated. Results There was no significant difference between the two groups in operative time and complication rate. The estimated blood loss and the length of hospital stay in the PETLIF group were significantly better than those in the MISTLIF group. Compared with those before operation, the postoperative VAS-L and VAS-B scores were significantly improved after operation in the both groups. In addition, the postoperative VAS-B score of the PETLIF group was significantly lower than that of the MISTLIF group. At the last follow-up, there was no significant difference between the two groups in the VAS-L score, VAS-B score, ODI score, and bony fusion rate. Conclusions Both PETLIF and MISTLIF could achieve satisfactory clinical outcomes in the treatment of lumbar degenerative disease, but our study suggested that PETLIF had less damage, rapid recovery after operation, and short discharge time.You-Di XueWen-Bo DiaoChao MaJie LiBMCarticlePercutaneous endoscopic transforaminal lumbar interbody fusionPETLIFMinimally invasive surgery-transforaminal lumbar interbody fusionMISTLIFDegenerative lumbar diseaseSpinal surgeryOrthopedic surgeryRD701-811Diseases of the musculoskeletal systemRC925-935ENJournal of Orthopaedic Surgery and Research, Vol 16, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Percutaneous endoscopic transforaminal lumbar interbody fusion
PETLIF
Minimally invasive surgery-transforaminal lumbar interbody fusion
MISTLIF
Degenerative lumbar disease
Spinal surgery
Orthopedic surgery
RD701-811
Diseases of the musculoskeletal system
RC925-935
spellingShingle Percutaneous endoscopic transforaminal lumbar interbody fusion
PETLIF
Minimally invasive surgery-transforaminal lumbar interbody fusion
MISTLIF
Degenerative lumbar disease
Spinal surgery
Orthopedic surgery
RD701-811
Diseases of the musculoskeletal system
RC925-935
You-Di Xue
Wen-Bo Diao
Chao Ma
Jie Li
Lumbar degenerative disease treated by percutaneous endoscopic transforaminal lumbar interbody fusion or minimally invasive surgery-transforaminal lumbar interbody fusion: a case-matched comparative study
description Abstract Purpose This study aimed to evaluate the clinical efficacy and imaging results of percutaneous endoscopic transforaminal lumbar interbody fusion (PETLIF) through comparing it with minimally invasive surgery-transforaminal lumbar interbody fusion (MISTLIF). Materials and methods We performed a retrospective analysis on patients with lumbar degenerative disease treated by PETLIF or MISTLIF from September 2017 to January 2019, and the patients were divided into two groups: the PETLIF group and the MISTLIF group. The clinical and imaging parameters of the two groups were evaluated. Results There was no significant difference between the two groups in operative time and complication rate. The estimated blood loss and the length of hospital stay in the PETLIF group were significantly better than those in the MISTLIF group. Compared with those before operation, the postoperative VAS-L and VAS-B scores were significantly improved after operation in the both groups. In addition, the postoperative VAS-B score of the PETLIF group was significantly lower than that of the MISTLIF group. At the last follow-up, there was no significant difference between the two groups in the VAS-L score, VAS-B score, ODI score, and bony fusion rate. Conclusions Both PETLIF and MISTLIF could achieve satisfactory clinical outcomes in the treatment of lumbar degenerative disease, but our study suggested that PETLIF had less damage, rapid recovery after operation, and short discharge time.
format article
author You-Di Xue
Wen-Bo Diao
Chao Ma
Jie Li
author_facet You-Di Xue
Wen-Bo Diao
Chao Ma
Jie Li
author_sort You-Di Xue
title Lumbar degenerative disease treated by percutaneous endoscopic transforaminal lumbar interbody fusion or minimally invasive surgery-transforaminal lumbar interbody fusion: a case-matched comparative study
title_short Lumbar degenerative disease treated by percutaneous endoscopic transforaminal lumbar interbody fusion or minimally invasive surgery-transforaminal lumbar interbody fusion: a case-matched comparative study
title_full Lumbar degenerative disease treated by percutaneous endoscopic transforaminal lumbar interbody fusion or minimally invasive surgery-transforaminal lumbar interbody fusion: a case-matched comparative study
title_fullStr Lumbar degenerative disease treated by percutaneous endoscopic transforaminal lumbar interbody fusion or minimally invasive surgery-transforaminal lumbar interbody fusion: a case-matched comparative study
title_full_unstemmed Lumbar degenerative disease treated by percutaneous endoscopic transforaminal lumbar interbody fusion or minimally invasive surgery-transforaminal lumbar interbody fusion: a case-matched comparative study
title_sort lumbar degenerative disease treated by percutaneous endoscopic transforaminal lumbar interbody fusion or minimally invasive surgery-transforaminal lumbar interbody fusion: a case-matched comparative study
publisher BMC
publishDate 2021
url https://doaj.org/article/d0a846fb03334701a23323bcb96faaef
work_keys_str_mv AT youdixue lumbardegenerativediseasetreatedbypercutaneousendoscopictransforaminallumbarinterbodyfusionorminimallyinvasivesurgerytransforaminallumbarinterbodyfusionacasematchedcomparativestudy
AT wenbodiao lumbardegenerativediseasetreatedbypercutaneousendoscopictransforaminallumbarinterbodyfusionorminimallyinvasivesurgerytransforaminallumbarinterbodyfusionacasematchedcomparativestudy
AT chaoma lumbardegenerativediseasetreatedbypercutaneousendoscopictransforaminallumbarinterbodyfusionorminimallyinvasivesurgerytransforaminallumbarinterbodyfusionacasematchedcomparativestudy
AT jieli lumbardegenerativediseasetreatedbypercutaneousendoscopictransforaminallumbarinterbodyfusionorminimallyinvasivesurgerytransforaminallumbarinterbodyfusionacasematchedcomparativestudy
_version_ 1718407985393303552